{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:49:47Z","timestamp":1758811787271},"reference-count":32,"publisher":"China Science Publishing & Media Ltd.","issue":"11","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2022,11,1]]},"DOI":"10.3724\/abbs.2022163","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T07:01:48Z","timestamp":1667804508000},"page":"1630-1636","update-policy":"http:\/\/dx.doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["An ultrasensitive, rapid and portable method for screening oseltamivir-resistant virus based on CRISPR\/Cas12a combined with immunochromatographic strips"],"prefix":"10.3724","volume":"54","author":[{"given":"Hao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fayu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenzhong","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feiqun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuangang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingchun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/(SICI)1099-1654(200003\/04)10:2<119::AID-RMV272>3.0.CO;2-O","volume":"10","author":"Oxford JS","year":"2000","unstructured":"Oxford JS. Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology. Rev Med Virol, 2000, 10: 119-133.","journal-title":"Rev Med Virol"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1353\/bhm.2002.0022","volume":"76","author":"Johnson NP","year":"2002","unstructured":"Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 \"Spanish\" influenza pandemic. Bull History Med, 2002, 76: 105-115.","journal-title":"Bull History Med"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1126\/science.1176225","volume":"325","author":"Garten RJ","year":"2018","unstructured":"Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science, 2018, 325: 197-201.","journal-title":"Science"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1128\/JVI.02565-08","volume":"83","author":"Dunham EJ","year":"2009","unstructured":"Dunham EJ, Dugan VG, Kaser EK, Perkins SE, Brown IH, Holmes EC, Taubenberger JK. Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses. J Virol, 2009, 83: 5485-5494.","journal-title":"J Virol"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.chom.2010.05.009","volume":"7","author":"Taubenberger JK","year":"2010","unstructured":"Taubenberger JK, Kash JC. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe, 2010, 7: 440-451.","journal-title":"Cell Host Microbe"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1586\/14760584.2016.1115352","volume":"15","author":"He F","year":"2016","unstructured":"He F, Leyrer S, Kwang J. Strategies towards universal pandemic influenza vaccines. Expert Rev Vaccines, 2016, 15: 215-225.","journal-title":"Expert Rev Vaccines"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1016\/j.vaccine.2010.03.068","volume":"28","author":"Prieto-Lara E","year":"2010","unstructured":"Prieto-Lara E, Llanos-M\u00e9ndez A. Safety and immunogenicity of prepandemic H5N1 influenza vaccines: a systematic review of the literature. Vaccine, 2010, 28: 4328-4334.","journal-title":"Vaccine"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s13054-019-2616-1","volume":"23","author":"Kain T","year":"2019","unstructured":"Kain T, Fowler R. Preparing intensive care for the next pandemic influenza. Crit Care, 2019, 23:","journal-title":"Crit Care"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/nyas.12462","volume":"1323","author":"Webster RG","year":"2014","unstructured":"Webster RG, Govorkova EA. Continuing challenges in influenza. Ann NY Acad Sci, 2014, 1323: 115-139.","journal-title":"Ann NY Acad Sci"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jinf.2010.10.003","volume":"62","author":"Jackson RJ","year":"2011","unstructured":"Jackson RJ, Cooper KL, Tappenden P, Rees A, Simpson EL, Read RC, Nicholson KG. Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review. J Infect, 2011, 62: 14-25.","journal-title":"J Infect"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3201\/eid0404.980402","volume":"4","author":"Domingo E","year":"1998","unstructured":"Domingo E, Baranowski E, Ruiz-Jarabo CM, Mart\u00edn-Hern\u00e1ndez AM, S\u00e1iz JC, Escarm\u00eds C. Quasispecies structure and persistence of RNA viruses. Emerg Infect Dis, 1998, 4: 521-527.","journal-title":"Emerg Infect Dis"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","volume":"364","author":"Kiso M","year":"2004","unstructured":"Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden FG. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet, 2004, 364: 759-765.","journal-title":"Lancet"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/4371108a","volume":"437","author":"Le QM","year":"2005","unstructured":"Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND. isolation of drug-resistant H5N1 virus. Nature, 2005, 437:","journal-title":"Nature"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1126\/science.1187816","volume":"328","author":"Bloom JD","year":"2010","unstructured":"Bloom JD, Gong LI, Baltimore D. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science, 2010, 328: 1272-1275.","journal-title":"Science"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/nature06956","volume":"453","author":"Collins PJ","year":"2008","unstructured":"Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, Walker PA, Skehel JJ. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature, 2008, 453: 1258-1261.","journal-title":"Nature"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41564-019-0401-1","volume":"4","author":"Yasuhara A","year":"2019","unstructured":"Yasuhara A, Yamayoshi S, Kiso M, Sakai-Tagawa Y, Koga M, Adachi E, Kikuchi T. Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus. Nat Microbiol, 2019, 4: 1024-1034.","journal-title":"Nat Microbiol"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/18715265112129990006","volume":"13","author":"Dixit R","year":"2013","unstructured":"Dixit R, Khandaker G, Ilgoutz S, Rashid H, Booy R. Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic. Infectious Disorders Drug Targets, 2013, 13: 34-45.","journal-title":"Infectious Disorders Drug Targets"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jmoldx.2012.11.007","volume":"15","author":"van der Vries E","year":"2013","unstructured":"van der Vries E, Anber J, van der Linden A, Wu Y, Maaskant J, Stadhouders R, van Beek R. Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations. J Mol Diagnostics, 2013, 15: 347-354.","journal-title":"J Mol Diagnostics"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1126\/science.aam9321","volume":"356","author":"Gootenberg JS","year":"2017","unstructured":"Gootenberg JS, Abudayyeh OO, Lee JW, Essletzbichler P, Dy AJ, Joung J, Verdine V. Nucleic acid detection with CRISPR-Cas13a\/C2c2. Science, 2017, 356: 438-442.","journal-title":"Science"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.aar6245","volume":"360","author":"Chen JS","year":"2018","unstructured":"Chen JS, Ma E, Harrington LB, Da Costa M, Tian X, Palefsky JM, Doudna JA. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science, 2018, 360: 436-439.","journal-title":"Science"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1038\/s41467-020-18575-6","volume":"11","author":"Ding X","year":"2020","unstructured":"Ding X, Yin K, Li Z, Lalla RV, Ballesteros E, Sfeir MM, Liu C. Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay. Nat Commun, 2020, 11:","journal-title":"Nat Commun"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s41587-020-0513-4","volume":"38","author":"Broughton JP","year":"2020","unstructured":"Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, Miao X. CRISPR\u2013Cas12-based detection of SARS-CoV-2. Nat Biotechnol, 2020, 38: 870-874.","journal-title":"Nat Biotechnol"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-020-2279-8","volume":"582","author":"Ackerman CM","year":"2020","unstructured":"Ackerman CM, Myhrvold C, Thakku SG, Freije CA, Metsky HC, Yang DK, Ye SH. Massively multiplexed nucleic acid detection with Cas13. Nature, 2020, 582: 277-282.","journal-title":"Nature"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ymthe.2020.09.025","volume":"29","author":"Neggers JE","year":"2021","unstructured":"Neggers JE, Jacquemyn M, Dierckx T, Kleinstiver BP, Thibaut HJ, Daelemans D. enAsCas12a enables CRISPR-directed evolution to screen for functional drug resistance mutations in sequences inaccessible to SpCas9. Mol Ther, 2021, 29: 208-224.","journal-title":"Mol Ther"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1038\/srep05405","volume":"4","author":"Zhang Y","year":"2014","unstructured":"Zhang Y, Ge X, Yang F, Zhang L, Zheng J, Tan X, Jin ZB. Comparison of non-canonical PAMs for CRISPR\/Cas9-mediated DNA cleavage in human cells. Sci Rep, 2014, 4:","journal-title":"Sci Rep"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.bios.2015.11.099","volume":"78","author":"Fu X","year":"2016","unstructured":"Fu X, Cheng Z, Yu J, Choo P, Chen L, Choo J. A SERS-based lateral flow assay biosensor for highly sensitive detection of HIV-1 DNA. Biosens Bioelectron, 2016, 78: 530-537.","journal-title":"Biosens Bioelectron"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"130411","DOI":"10.1016\/j.snb.2021.130411","volume":"345","author":"Zhang Y","year":"2021","unstructured":"Zhang Y, Chen M, Liu C, Chen J, Luo X, Xue Y, Liang Q. Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR\/Cas12-assisted RT-LAMP. Sens Actuat B-Chem, 2021, 345:","journal-title":"Sens Actuat B-Chem"},{"key":"CITATION28","doi-asserted-by":"crossref","unstructured":"Lucia C, Federico PB, Alejandra GC. An ultrasensitive, rapid, and portable coronavirus. SARS-CoV-2 sequence detection method based on CRISPR-Cas12.                                                      bioRxiv                          2020, doi.org\/10.1101\/2020.02.29.971127.","DOI":"10.1101\/2020.02.29.971127"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41467-021-21996-6","volume":"12","author":"Ooi KH","year":"2021","unstructured":"Ooi KH, Liu MM, Tay JW, Teo SY, Kaewsapsak P, Jin S, Lee CK. An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing. Nat Commun, 2021, 12:","journal-title":"Nat Commun"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"11295","DOI":"10.1093\/nar\/gkx783","volume":"45","author":"Tu M","year":"2017","unstructured":"Tu M, Lin L, Cheng Y, He X, Sun H, Xie H, Fu J. A \u2018new lease of life\u2019: FnCpf1 possesses DNA cleavage activity for genome editing in human cells. Nucleic Acids Res, 2017, 45: 11295-11304.","journal-title":"Nucleic Acids Res"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0140-6736(99)11433-8","volume":"355","author":"Gubareva LV","year":"2000","unstructured":"Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet, 2000, 355: 827-835.","journal-title":"Lancet"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jcv.2016.11.008","volume":"86","author":"Granados A","year":"2017","unstructured":"Granados A, Peci A, McGeer A, Gubbay JB. Influenza and rhinovirus viral load and disease severity in upper respiratory tract infections. J Clin Virol, 2017, 86: 14-19.","journal-title":"J Clin Virol"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/62AC312A01094E3E9EF0821F54233A2D","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2022163","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/62AC312A01094E3E9EF0821F54233A2D","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T06:31:28Z","timestamp":1672122688000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2022163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,7]]},"published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2022163","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,1]]}}}